Inovio Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The analysis of Inovio Pharmaceuticals Inc is assembled by All Street Sevva using proprietary Cognitive Robots. The Disclosure score covers seventeen United Nations Sustainable Development Goals including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Life below Water'. Full Sustainability assessment of Inovio Pharmaceuticals Inc are accessed by logging in.
Inovio Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 4.0, social score of 1.6 and governance score of 6.4.
4.0
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
989 | Tricida Inc | 4.1 | High |
1004 | Inovio Pharmaceuticals Inc | 4.0 | High |
1004 | Can B Corp | 4.0 | High |
1004 | CLS Holdings USA Inc | 4.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Inovio Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Inovio Pharmaceuticals Inc disclose current and historical energy intensity?
Does Inovio Pharmaceuticals Inc report the average age of the workforce?
Does Inovio Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Inovio Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Inovio Pharmaceuticals Inc disclose cybersecurity risks?
Does Inovio Pharmaceuticals Inc offer flexible work?
Does Inovio Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Inovio Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Inovio Pharmaceuticals Inc conduct supply chain audits?
Does Inovio Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Inovio Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Inovio Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Inovio Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Inovio Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Inovio Pharmaceuticals Inc disclose water use targets?
Does Inovio Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Inovio Pharmaceuticals Inc have a product recall in the last two years?
Does Inovio Pharmaceuticals Inc disclose incidents of discrimination?
Does Inovio Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Inovio Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Inovio Pharmaceuticals Inc disclose parental leave metrics?
Does Inovio Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Inovio Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Inovio Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Inovio Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Inovio Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Inovio Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Inovio Pharmaceuticals Inc involved in embryonic stem cell research?
Does Inovio Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Inovio Pharmaceuticals Inc disclose its waste policy?
Does Inovio Pharmaceuticals Inc report according to TCFD requirements?
Does Inovio Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Inovio Pharmaceuticals Inc disclose energy use targets?
Does Inovio Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Inovio Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Inovio Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.